We are delighted to share that PurCell Bio has officially joined the esteemed Alliance for Regenerative Medicine (ARM), a premier international advocacy organization dedicated to advancing the field of engineered cell therapies and genetic medicines.

As a global leader, ARM champions the benefits of regenerative medicine for patients, healthcare systems, and society. With over 400 members spanning 25 countries, ARM brings together emerging and established biotechnology companies, academic and medical research institutions, and patient organizations to shape the future of medicine.

Why ARM Membership Matters?

Advocacy for Effective Policies:

Participation in ARM enables PurCell Bio to advocate for effective policies that support the development and adoption of regenerative medicine. This includes engaging with key government agencies such as the FDA, CMS, NIH, and EMA to influence regulatory pathways and reimbursement frameworks.

Influence on Sector Initiatives:

By joining ARM, PurCell Bio can actively contribute to shaping legislative and regulatory priorities, addressing sector opportunities, and collectively working towards overcoming challenges in the field.

Science & Technology Collaboration:

ARM provides a platform for PurCell Bio to collaborate with industry experts, sharing and improving innovative approaches to process development, manufacturing, control, and distribution of cell and gene medicines.

Extensive Networking Opportunities

Membership in ARM facilitates connections with commercial leaders, potential partners, patient advocacy groups, and research institutions through participation in ARM events, Advisory Groups, Forums, and Working Groups.

Capital Formation Exposure:

PurCell Bio gains exposure to the international investment community through ARM events, presentation opportunities, and the extensive ARM network.

Access to ARM Events and Industry Information:

ARM membership offers access to exclusive speaking opportunities, special rates for ARM and other industry events, and the most current industry data, including financings, partnerships, clinical trials, and key regulatory and policy changes.

Increased Visibility and Engagement:

PurCell Bio can showcase its accomplishments, priorities, and opportunities to a diverse multi-stakeholder audience at various ARM events throughout the year.

Joining ARM aligns with PurCell Bio’s commitment to innovation and collaboration in the regenerative medicine sector. We look forward to contributing to ARM’s mission and leveraging this partnership to drive positive advancements in our field.

Read more about ARM: https://alliancerm.org/arm-impact/